Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.98
+0.32 (4.80%)
At close: Mar 6, 2026, 4:00 PM EST
6.65
-0.33 (-4.73%)
After-hours: Mar 6, 2026, 7:55 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $42.95 million as of March 6, 2026. Its market cap has decreased by -44.50% in one year.
Market Cap
42.95M
Enterprise Value
-29.64M
1-Year Change
-44.50%
Ranking
Category
Stock Price
$6.98
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $42.95M, a decrease of -92.24%. That is a compound annual growth rate of -37.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 43.27M |
| OnKure Therapeutics | 43.08M |
| Lite Strategy | 41.09M |
| Veru Inc. | 41.09M |
| Atossa Therapeutics | 40.30M |
| Palatin Technologies | 39.87M |
| Xilio Therapeutics | 39.77M |
| NovaBay Pharmaceuticals | 38.66M |